DE69636778D1 - Retinsäurepropyleneglycolester enthaltender Kosmetikum ZUR ANWENDUNG AUF DER HAUT SOWIE ARZNEIMITTEL ZUR BEHANDLUNG VON Hautkrankheiten, TUMORÖSEN ZELLEN UND BLASEN-ODER NERVENSTÖRUNGEN - Google Patents

Retinsäurepropyleneglycolester enthaltender Kosmetikum ZUR ANWENDUNG AUF DER HAUT SOWIE ARZNEIMITTEL ZUR BEHANDLUNG VON Hautkrankheiten, TUMORÖSEN ZELLEN UND BLASEN-ODER NERVENSTÖRUNGEN

Info

Publication number
DE69636778D1
DE69636778D1 DE69636778T DE69636778T DE69636778D1 DE 69636778 D1 DE69636778 D1 DE 69636778D1 DE 69636778 T DE69636778 T DE 69636778T DE 69636778 T DE69636778 T DE 69636778T DE 69636778 D1 DE69636778 D1 DE 69636778D1
Authority
DE
Germany
Prior art keywords
skin
medicines
bladder
treatment
propylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636778T
Other languages
English (en)
Inventor
Khodor Ammar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69636778D1 publication Critical patent/DE69636778D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69636778T 1995-06-30 1996-06-27 Retinsäurepropyleneglycolester enthaltender Kosmetikum ZUR ANWENDUNG AUF DER HAUT SOWIE ARZNEIMITTEL ZUR BEHANDLUNG VON Hautkrankheiten, TUMORÖSEN ZELLEN UND BLASEN-ODER NERVENSTÖRUNGEN Expired - Lifetime DE69636778D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95TO000551A IT1276459B1 (it) 1995-06-30 1995-06-30 Composizioni cosmetiche con proprieta' antimicotiche, efficaci contro la psoriasi e la caduta dei capelli e metodo cosmetico per la
PCT/IT1996/000129 WO1997002030A1 (en) 1995-06-30 1996-06-27 A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders

Publications (1)

Publication Number Publication Date
DE69636778D1 true DE69636778D1 (de) 2007-02-01

Family

ID=11413690

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636778T Expired - Lifetime DE69636778D1 (de) 1995-06-30 1996-06-27 Retinsäurepropyleneglycolester enthaltender Kosmetikum ZUR ANWENDUNG AUF DER HAUT SOWIE ARZNEIMITTEL ZUR BEHANDLUNG VON Hautkrankheiten, TUMORÖSEN ZELLEN UND BLASEN-ODER NERVENSTÖRUNGEN

Country Status (6)

Country Link
US (2) US6319957B1 (de)
EP (1) EP0836476B1 (de)
AU (1) AU6241096A (de)
DE (1) DE69636778D1 (de)
IT (1) IT1276459B1 (de)
WO (1) WO1997002030A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9907461D0 (en) * 1999-03-31 1999-05-26 King S College London Neurite regeneration
WO2001075135A1 (en) * 2000-03-30 2001-10-11 Oxford Biomedica (Uk) Limited Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders
IT1304656B1 (it) * 1998-09-23 2001-03-28 Khodor Ammar Derivati dell'acido retinoico per uso medicinale e relativometodo di preparazione.
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
NZ516873A (en) * 2001-02-12 2003-11-28 Warner Lambert Co Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage
US7189759B2 (en) * 2001-05-23 2007-03-13 Medicis Pharmaceutical Corporation Compositions for the treatment of pigmentation disorders and methods for their manufacture
US20090203628A1 (en) * 2008-02-12 2009-08-13 Jan Marini Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition
ES2327201B1 (es) * 2008-04-23 2010-07-23 Ignacio Umbert Millet Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico.
ES2378028B1 (es) 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
US8603549B1 (en) 2012-05-25 2013-12-10 Svetlana Baker Systems and methods for inhibiting formation of stretch marks
EP3090741B1 (de) * 2015-02-06 2019-07-10 Orlandi, Augusto Direkte fungistatische wirkung von retinsäure auf candida albicans und aspergillus fumigatus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR472225A (fr) 1913-05-20 1914-11-26 Azulay Syndicate Ltd Perfectionnements apportés aux machines pour la fabrication d'objets ou de matière composée de caoutchouc ou autre matière adhésive et de fibre
NL257621A (de) * 1959-11-23
US4216224A (en) * 1978-09-22 1980-08-05 Scott Eugene J Van Methods and compositions for treating psoriasis with retinoyl compounds
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US4677120A (en) * 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
US4885311A (en) * 1987-06-29 1989-12-05 Molecular Design International Topical transretinoids for treatment of acne and skin diseases
EP0397774A1 (de) * 1988-02-04 1990-11-22 Board Of Regents, The University Of Texas System Formulierung und anwendung von retinoiden für behandlung von krebs und anderen krankheiten
US5043356A (en) * 1990-01-19 1991-08-27 Fulton Jr James E Composition and method for rejuvenating skin using vitamin A propionate
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
US5686086A (en) * 1992-07-13 1997-11-11 Shiseido Co., Ltd. External skin treatment composition

Also Published As

Publication number Publication date
ITTO950551A1 (it) 1996-12-30
EP0836476B1 (de) 2006-12-20
US6319957B1 (en) 2001-11-20
US20020037305A1 (en) 2002-03-28
EP0836476A1 (de) 1998-04-22
WO1997002030A1 (en) 1997-01-23
ITTO950551A0 (it) 1995-06-30
AU6241096A (en) 1997-02-05
IT1276459B1 (it) 1997-10-31

Similar Documents

Publication Publication Date Title
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
DE69512685T2 (de) Mittel zur verabreichung von wirksubstanzen an bzw. durch die haut
ATE232543T1 (de) 11beta-halogen-7alpha-substituierte-estratriene verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha- substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln
PL333284A1 (en) Methods for medicinal treatment of skin pigmentation
IL127943A0 (en) Pharmaceutical and cosmetic composition for the treatment of skin disorders
ATE290397T1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
ATE99932T1 (de) Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis.
DE69636778D1 (de) Retinsäurepropyleneglycolester enthaltender Kosmetikum ZUR ANWENDUNG AUF DER HAUT SOWIE ARZNEIMITTEL ZUR BEHANDLUNG VON Hautkrankheiten, TUMORÖSEN ZELLEN UND BLASEN-ODER NERVENSTÖRUNGEN
NO975192L (no) Bicykliske aromatiske forbindelser
DE69315927T2 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
AU2001240940A1 (en) Cosmetic and dermatological composition for psoriatic skin, scalp treatment and care
DE69600118T2 (de) Verwendung der Benzosäurederivate zur Stimulierung die Erneuerung der Epidermis und zur Behandlung der Haut
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
DE59506539D1 (de) Hydrogel für die applikation von therapeutischen und/oder kosmetischen wirkstoffen an die haut
DE69822276T2 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
NO995231D0 (no) Terapeutisk behandling av hudlidelser
FR2757391B1 (fr) Utilisation d'un extrait de la plante terminalia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique
AU6968098A (en) Topical treatment of skin diseases and eye afflictions
CA2100720A1 (en) Medicinal composition comprising tcf-ii
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
NO20000376D0 (no) Transdermalt terapeutisk system for frigiving av virkestoff gjennom huden inn i en organisme og fremgangsmåte for påfoering på huden
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
AU2509801A (en) Method for the cosmetic treatment of human skin
BG105924A (en) Composition for the treatment of psoriasis

Legal Events

Date Code Title Description
8332 No legal effect for de